SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2026 RESULTS REAFFIRMS FULL YEAR 2026 GUIDANCE (Form 8-K)

SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2026 RESULTS

REAFFIRMS FULL YEAR 2026 GUIDANCE

BRENTWOOD, Tenn., August 10, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2026.

Second Quarter 2026 Financial Highlights

(All comparisons are year-over-year unless otherwise noted)

•Revenue increased 2.7% for the second quarter

◦Same-facility revenues increased 5.0% for the second quarter

◦Same-facility cases increased 0.3% for the second quarter

•Net loss attributable to Surgery Partners, Inc. was $15.0 million for the second quarter

◦Adjusted EBITDA was $125.2 million for the second quarter

2026 Guidance

•Full year 2026 revenue guidance reaffirmed to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million, excluding recently disclosed pending divestiture

Eric Evans, Chief Executive Officer, stated, "We are pleased with our progress this quarter, which reflects disciplined execution against our key strategic priorities to support a return to growth and reinforces our conviction in our short stay surgical platform. The announcement of the pending Idaho Falls transaction was a key achievement and represents an important step forward in our portfolio optimization strategy, as we take decisive actions to improve our financial profile and sharpen our strategic focus. Looking ahead, we will capitalize on the structural tailwinds underpinning long-term ASC market growth, enhance operational efficiency, and thoughtfully deploy capital to deliver long-term value for our shareholders."

Dave Doherty, Chief Financial Officer, commented, "Our financial results in the second quarter demonstrate the momentum of our ongoing initiatives to improve performance, and we are reiterating full-year guidance as a result. The Idaho Falls transaction, which remains subject to closing conditions including physician members and governing board approvals, will further strengthen our financial position, through improved cash conversion and deleveraging. Going forward, we are committed to disciplined capital allocation to support the continued growth of our business."

Second Quarter 2026 Results

Revenues for the second quarter of 2026 increased 2.7% to $848.9 million compared to $826.2 million for the second quarter of 2025. Same-facility revenues for the second quarter of 2026 increased 5.0% as compared to the same period in prior year, with a 4.8% increase in revenue per case and a 0.3% increase in same-facility cases. For the second quarter of 2026, the Company's Adjusted EBITDA was $125.2 million, compared to $129.0 million for the same period in 2025.

Year-to-Date 2026 Results

Revenues year-to-date 2026 increased 3.6% to $1,659.8 million compared to $1,602.2 million for the 2025 period. Same-facility revenues for year-to-date 2026 increased 4.9% as compared to the prior year, with a 4.0% increase in revenue per case and a 0.8% increase in same-facility cases. For year-to-date 2026, the Company's Adjusted EBITDA was $227.5 million, compared to $232.9 million for the same period last year.

Liquidity

Surgery Partners had cash and cash equivalents of $216.7 million and $617.8 million of borrowing capacity under its revolving credit facility as of June 30, 2026. Cash flows from operating activities were $59.3 million for the second quarter of

1

2026, compared to $81.3 million for the same period in 2025. Year-to-date, operating cash flows were $71.0 million compared to $87.3 million in the prior year period.

The Company's ratio of total net debt to EBITDA, as calculated under the Company's credit agreement, was approximately 4.4x at the end of the second quarter of 2026.

2026 Outlook

The Company reaffirmed its outlook for 2026 revenues to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million, excluding the impact of the recently disclosed pending divestiture of our facilities in Idaho Falls, Idaho.

Conference Call Information

Surgery Partners will hold a conference call today, August 10, 2026 at 8:30 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-451-6152, or for international callers, 1-201-389-0879. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13761354. The replay will be available until August 24, 2026.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call.

To learn more about Surgery Partners, please visit the Company's website at www.surgerypartners.com. Surgery Partners uses its website as a channel of distribution for material Company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company's website and is readily accessible.

About Surgery Partners

Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com.